Drug data last refreshed 4h ago · AI intelligence enriched 6d ago
IMODIUM MULTI-SYMPTOM RELIEF is a fixed-dose combination oral tablet containing loperamide hydrochloride (an antimotility agent) and simethicone (an anti-gas agent) for symptomatic relief of diarrhea and associated gas/bloating. This OTC product targets consumers seeking rapid multi-symptom relief in the gastrointestinal category without prescription requirements.
As an OTC product with LOE approaching, the brand team is likely focused on line extensions, formulation innovation, or lifecycle management rather than expansion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on IMODIUM MULTI-SYMPTOM offers experience in mature-market brand management, OTC portfolio strategy, and retail/consumer-facing operations within Johnson & Johnson's consumer health division. Career progression typically involves P&L ownership, retail partnerships, and lifecycle renewal strategies rather than clinical innovation.
Worked on IMODIUM MULTI-SYMPTOM RELIEF at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.